Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and computational biology. The journal was established in 1974 by Benjamin Lewin and is published twice monthly by Cell Press, an imprint of Elsevier. Benjamin Lewin founded Cell in January 1974, under the aegis of MIT Press. He then bought the title and established an independent Cell Press in 1986. In April 1999, Lewin sold Cell Press to Elsevier. The "Article of the Future" feature was the recipient of a 2011 PROSE Award for Excellence in Biological & Life Sciences presented by the Professional and Scholarly Publishing Division of the Association of American Publishers. According to ScienceWatch, the journal was ranked first overall in the category of highest-impact journals (all fields) over 1995–2005 with an average of 161.2 citations per paper.

Publisher
Cell Press
History
1974–present
Website
http://www.cell.com/
Impact factor
32.401 (2010)

Some content from Wikipedia, licensed under CC BY-SA

How to read a jellyfish's mind

The human brain has 100 billion neurons, making 100 trillion connections. Understanding the precise circuits of brain cells that orchestrate all of our day-to-day behaviors—such as moving our limbs, responding to fear and ...

Origins of the Avars elucidated with ancient DNA

Less known than Attila's Huns, the Avars were their more successful successors. They ruled much of Central and Eastern Europe for almost 250 years. We know that they came from Central Asia in the sixth century CE, but ancient ...

So-called junk DNA plays critical role in mammalian development

Nearly half of our DNA has been written off as junk, the discards of evolution: Sidelined or broken genes, viruses that got stuck in our genome and were dismembered or silenced, none of it relevant to the human organism or ...

'Ultra-potent' antibody against COVID-19 variants

A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta ...

page 1 from 22